I agree that this site is using cookies. You can find further informations here.
X
Okubo, Tomomi
213  results:
Search for persons X
?
1

Kinetics of the hepatitis B core‐related antigen and treatm..:

Itokawa, Norio ; Atsukawa, Masanori ; Tsubota, Akihito...
Hepatology Research.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Outcomes of patients with hepatocellular carcinoma treated ..:

Tada, Toshifumi ; Kumada, Takashi ; Hiraoka, Atsushi...
Alimentary Pharmacology & Therapeutics.  60 (2024)  2 - p. 233-245 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Low vitamin D levels accelerates muscle mass loss in patien..:

Okubo, Tomomi ; Atsukawa, Masanori ; Tsubota, Akihito...
PLOS ONE.  19 (2024)  3 - p. e0299313 , 2024
Link: https://doi.org/10.1371/..
 
?
4

Assessment of Macrovascular Invasion in Advanced Hepatocell..:

Inoue, Masanori ; Ogasawara, Sadahisa ; Kobayashi, Kazufumi...
Liver Cancer.  , 2024
Link: https://doi.org/10.1159/..
 
?
5

Impact of pemafibrate in patients with metabolic dysfunctio..:

Ono, Hiroki ; Atsukawa, Masanori ; Tsubota, Akihito...
JGH Open.  8 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
6

SAT-236 Efficacy and safety of incretin-based therapies in ..:

Kawano, Tadamichi ; Arai, Taeang ; Atsukawa, Masanori...
Journal of Hepatology.  80 (2024)  - p. S616 , 2024
Link: https://doi.org/10.1016/..
 
?
7

ALBI score predicts morphological changes in esophageal var..:

Atsukawa, Masanori ; Tsubota, Akihito ; Kondo, Chisa...
Journal of Gastroenterology.  , 2024
Link: https://doi.org/10.1007/..
 
?
8

Clinical significance of circulating biomarkers of immune-c..:

Chuma, Makoto ; Uojima, Haruki ; Toyoda, Hidenori...
Hepatology International.  , 2024
Link: https://doi.org/10.1007/..
 
?
9

Ramucirumab for advanced hepatocellular carcinoma in the cu..:

Kobayashi, Kazufumi ; Ogasawara, Sadahisa ; Itobayashi, Ei...
Investigational New Drugs.  , 2024
Link: https://doi.org/10.1007/..
 
?
10

SAT-101 Morphological changes in esophageal varices in pati..:

Nagao, Chikako ; Atsukawa, Masanori ; Kawano, Tadamichi...
Journal of Hepatology.  80 (2024)  - p. S248-S249 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Hyperprogressive disease during atezolizumab plus bevacizum..:

Yumita, Sae ; Ogasawara, Sadahisa ; Nakagawa, Miyuki...
BMC Gastroenterology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
12

A novel formula used for predicting hepatocellular carcinom..:

Yoshida, Yuji ; Atsukawa, Masanori ; Kondo, Chisa...
PLOS ONE.  18 (2023)  9 - p. e0292019 , 2023
Link: https://doi.org/10.1371/..
 
?
13

Comparison of prognostic impact of atezolizumab plus bevaci..:

Tada, Toshifumi ; Kumada, Takashi ; Hiraoka, Atsushi...
Liver International.  44 (2023)  1 - p. 113-124 , 2023
Link: https://doi.org/10.1111/..
 
?
14

Cabozantinib for Advanced Hepatocellular Carcinoma in the L..:

Kanzaki, Hiroaki ; Ogasawara, Sadahisa ; Okubo, Tomomi...
Drugs - Real World Outcomes.  10 (2023)  4 - p. 513-520 , 2023
Link: https://doi.org/10.1007/..
 
?
15

Impact of new ESC/ERS diagnostic criteria for pulmonary hyp..:

Ono, Hiroki ; Atsukawa, Masanori ; Koyano, Kaori...
Journal of Hepatology.  78 (2023)  - p. S317 , 2023
Link: https://doi.org/10.1016/..
 
1-15